MCM
AZN icon

Maple Capital Management’s AstraZeneca AZN Stock Holding History

Maple Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,300
Closed -$210K – 124
2015
Q2 		$210K Hold
3,300
– – 0.07% 117
2015
Q1 		$226K Sell
3,300
-3,000
-48% -$208K 0.08% 117
2014
Q4 		$443K Hold
6,300
– – 0.16% 84
2014
Q3 		$450K Hold
6,300
– – 0.17% 78
2014
Q2 		$468K Buy
6,300
+500
+9% +$36.1K 0.17% 80
2014
Q1 		$376K Hold
5,800
– – 0.15% 90
2013
Q4 		$344K Buy
5,800
+625
+12% +$34K 0.14% 99
2013
Q3 		$269K Buy
5,175
+600
+13% +$30.1K 0.12% 103
2013
Q2 		$216K Buy
+4,575
New +$233K 0.1% 113

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return